<div id=toc></div>

# Table of Contents

- [q-bio.GN](#q-bio.GN) [Total: 1]
- [q-bio.QM](#q-bio.QM) [Total: 2]
- [stat.AP](#stat.AP) [Total: 1]
- [eess.IV](#eess.IV) [Total: 1]
- [cs.LG](#cs.LG) [Total: 1]


<div id='q-bio.GN'></div>

# q-bio.GN [[Back]](#toc)

### [1] [Detecting Batch Heterogeneity via Likelihood Clustering](https://arxiv.org/abs/2601.09758)
*Austin Talbot,Yue Ke*

Main category: q-bio.GN

TL;DR: 提出一种基于贝叶斯模型证据的批次效应检测方法，通过证据空间中的混合结构似然比检验区分技术变异与生物信号，在临床基因组诊断中优于传统方法。


<details>
  <summary>Details</summary>
Motivation: 基因组诊断中的批次效应是主要混杂因素，现有方法要么基于原始特征聚类（可能混淆生物信号与技术变异），要么需要已知批次标签（通常不可得），需要一种能区分技术变异与生物信号的方法。

Method: 基于贝叶斯模型证据聚类样本，利用技术伪影违反模型假设降低证据、而生物变异（包括CNV状态）被模型预期保持高证据的不对称性，将异质性检测形式化为证据空间中混合结构的似然比检验，使用参数自举校准确保保守的假阳性率。

Result: 在合成数据上验证了正确的I类错误控制，在三个临床靶向测序面板（液体活检、BRCA、地中海贫血）和跨模态的小鼠电生理记录上展示了优越的聚类准确性，相比标准基于相关性和降维方法更优，同时保持临床所需的保守性。

Conclusion: 该方法通过贝叶斯模型证据有效区分批次效应与生物变异，为临床基因组诊断提供可靠的批次效应检测工具，具有跨模态通用性。

Abstract: Batch effects represent a major confounder in genomic diagnostics. In copy number variant (CNV) detection from NGS, many algorithms compare read depth between test samples and a reference sample, assuming they are process-matched. When this assumption is violated, with causes ranging from reagent lot changes to multi-site processing, the reference becomes inappropriate, introducing false CNV calls or masking true pathogenic variants. Detecting such heterogeneity before downstream analysis is critical for reliable clinical interpretation. Existing batch effect detection methods either cluster samples based on raw features, risking conflation of biological signal with technical variation, or require known batch labels that are frequently unavailable. We introduce a method that addresses both limitations by clustering samples according to their Bayesian model evidence. The central insight is that evidence quantifies compatibility between data and model assumptions, technical artifacts violate assumptions and reduce evidence, whereas biological variation, including CNV status, is anticipated by the model and yields high evidence. This asymmetry provides a discriminative signal that separates batch effects from biology. We formalize heterogeneity detection as a likelihood ratio test for mixture structure in evidence space, using parametric bootstrap calibration to ensure conservative false positive rates. We validate our approach on synthetic data demonstrating proper Type I error control, three clinical targeted sequencing panels (liquid biopsy, BRCA, and thalassemia) exhibiting distinct batch effect mechanisms, and mouse electrophysiology recordings demonstrating cross-modality generalization. Our method achieves superior clustering accuracy compared to standard correlation-based and dimensionality-reduction approaches while maintaining the conservativeness required for clinical usage.

</details>


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [2] [Robust and Generalizable Atrial Fibrillation Detection from ECG Using Time-Frequency Fusion and Supervised Contrastive Learning](https://arxiv.org/abs/2601.10202)
*Hongtao Li,Jia Wei,Jia Xiao,Yuanjun Lai,Mingyang Liu,Shuzhen Lv,Xueqiang Ouyang*

Main category: q-bio.QM

TL;DR: 提出一种用于心房颤动检测的跨模态深度学习框架，包含双向门控模块和跨模态监督对比学习策略，在多个数据集上实现了优异的鲁棒性和泛化能力。


<details>
  <summary>Details</summary>
Motivation: 心房颤动是常见的心律失常，显著增加中风和心力衰竭风险，需要从心电图记录中开发可靠且可泛化的检测方法。现有深度学习方法难以有效利用互补的时频信息，在数据集内鲁棒性和跨数据集泛化方面存在局限。

Method: 提出跨模态深度学习框架，包含两个关键组件：1）双向门控模块（BGM），促进时域和频域特征之间的动态互惠细化；2）跨模态监督对比学习（CSCL）策略，通过拉近标签一致的样本和推开不同的样本来显式结构化联合嵌入空间。

Result: 在AFDB和CPSC2021数据集上进行五折交叉验证和双向跨数据集实验，结果显示在多个指标上持续优于最先进方法，实现了高数据集内鲁棒性和优异的跨数据集泛化能力，同时具有高计算效率和抗干扰能力。

Conclusion: 该跨模态深度学习框架通过有效整合时频信息和结构化嵌入空间，显著提升了心房颤动检测的鲁棒性和泛化性能，适合边缘部署，为临床心电图分析提供了实用解决方案。

Abstract: Atrial fibrillation (AF) is a common cardiac arrhythmia that significantly increases the risk of stroke and heart failure, necessitating reliable and generalizable detection methods from electrocardiogram (ECG) recordings. Although deep learning has advanced automated AF diagnosis, existing approaches often struggle to exploit complementary time-frequency information effectively, limiting both robustness under intra-dataset and generalization across diverse clinical datasets. To address these challenges, we propose a cross-modal deep learning framework comprising two key components: a Bidirectional Gating Module (BGM) and a Cross-modal Supervised Contrastive Learning (CSCL) strategy. The BGM facilitates dynamic, reciprocal refinement between time and frequency domain features, enhancing model robustness to signal variations within a dataset. Meanwhile, CSCL explicitly structures the joint embedding space by pulling together label-consistent samples and pushing apart different ones, thereby improving inter-class separability and enabling strong cross-dataset generalization. We evaluate our method through five-fold cross-validation on the AFDB and the CPSC2021 dataset, as well as bidirectional cross-dataset experiments (training on one and testing on the other). Results show consistent improvements over state-of-the-art methods across multiple metrics, demonstrating that our approach achieves both high intra-dataset robustness and excellent cross-dataset generalization. We further demonstrate that our method achieves high computational efficiency and anti-interference capability, making it suitable for edge deployment.

</details>


### [3] [A Predictive Model for Synergistic Oncolytic Virotherapy: Unveiling the Ping-Pong Mechanism and Optimal Timing of Combined Vesicular Stomatitis and Vaccinia Viruses](https://arxiv.org/abs/2601.10405)
*Joseph Malinzi,Amina Eladdadi,Rachid Ouifki,Raluca Eftimie,Anotida Madzvamuse,Helen M. Byrne*

Main category: q-bio.QM

TL;DR: 提出描述VSV和VV联合治疗协同机制的数学模型，揭示VV感染细胞产生B18R蛋白中和干扰素-α，从而增强VSV在肿瘤内复制的"乒乓"协同效应，实现比单药更快的肿瘤清除。


<details>
  <summary>Details</summary>
Motivation: 研究溶瘤病毒疗法（OVT）中联合治疗的协同机制，特别是VSV和VV组合的相互作用，以克服单药治疗的局限性，提高肿瘤清除效率。

Method: 建立数学模型描述肿瘤细胞、病毒复制和干扰素介导的免疫反应之间的动态相互作用，通过数值模拟、分岔分析和敏感性分析研究协同机制和治疗参数。

Result: 联合治疗在约50天内实现完全肿瘤清除，比VV单药治疗（56天）加速11%，VSV单药无法根除肿瘤。分岔分析确定了病毒爆发规模和B18R抑制的临界阈值，敏感性分析显示感染率和爆发规模对疗效影响最大。

Conclusion: VSV和VV组合通过"乒乓"协同机制有效清除肿瘤，最佳治疗策略是立即给予VSV，然后在1-19天窗口内延迟给予VV，这为克服OVT的时机和剂量挑战提供了策略性方法。

Abstract: We present a mathematical model that describes the synergistic mechanism of combined Vesicular Stomatitis Virus (VSV) and Vaccinia Virus (VV). The model captures the dynamic interplay between tumor cells, viral replication, and the interferon-mediated immune response, revealing a `ping-pong' synergy where VV-infected cells produce B18R protein that neutralizes interferon-$α$, thereby enhancing VSV replication within the tumor. Numerical simulations demonstrate that this combination achieves complete tumor clearance in approximately 50 days, representing an 11\% acceleration compared to VV monotherapy (56 days), while VSV alone fails to eradicate tumors. Through bifurcation analysis, we identify critical thresholds for viral burst size and B18R inhibition, while sensitivity analysis highlights infection rates and burst sizes as the most influential parameters for treatment efficacy. Temporal optimization reveals that therapeutic outcomes are maximized through immediate VSV administration followed by delayed VV injection within a 1-19 day window, offering a strategic approach to overcome the timing and dosing challenges inherent in OVT.

</details>


<div id='stat.AP'></div>

# stat.AP [[Back]](#toc)

### [4] [MitoFREQ: A Novel Approach for Mitogenome Frequency Estimation from Top-level Haplogroups and Single Nucleotide Variants](https://arxiv.org/abs/2601.10464)
*Mikkel Meyer Andersen,Nicole Huber,Kimberly S Andreaggi,Tóra Oluffa Stenberg Olsen,Walther Parson,Charla Marshall*

Main category: stat.AP

TL;DR: MitoFREQ：一种基于顶级单倍群频率和稀有SNV频率估算线粒体基因组群体频率的新方法，适用于法医遗传学证据评估。


<details>
  <summary>Details</summary>
Motivation: 目前高质量线粒体全基因组序列的群体数据有限，法医遗传学中需要可靠的方法来评估线粒体DNA证据的统计价值。

Method: 利用HelixMTdb和gnomAD数据库，将给定线粒体基因组分类到30个顶级单倍群中，然后使用该单倍群内最稀有SNV的频率加权计算群体频率。仅需227个特定位点即可完成99.9%样本的分类。

Result: 该方法在高质量法医参考数据集和GenBank多样化线粒体基因组集合上均表现稳健，产生的似然比范围为100-100,000，显著增强了法医mtDNA证据的统计评估能力。

Conclusion: MitoFREQ为法医遗传学提供了一种可靠、稳健的线粒体基因组频率估算方法，已开发为开源R包，支持自定义频率输入，适用于不同质量样本。

Abstract: Lineage marker population frequencies can serve as one way to express evidential value in forensic genetics. However, for high-quality whole mitochondrial DNA genome sequences (mitogenomes), population data remain limited. In this paper, we offer a new method, MitoFREQ, for estimating the population frequencies of mitogenomes. MitoFREQ uses the mitogenome resources HelixMTdb and gnomAD, harbouring information from 195,983 and 56,406 mitogenomes, respectively. Neither HelixMTdb nor gnomAD can be queried directly for individual mitogenome frequencies, but offers single nucleotide variant (SNV) allele frequencies for each of 30 "top-level" haplogroups (TLHG). We propose using the HelixMTdb and gnomAD resources by classifying a given mitogenome within the TLHG scheme and subsequently using the frequency of its rarest SNV within that TLHG weighted by the TLHG frequency. We show that this method is guaranteed to provide a higher population frequency estimate than if a refined haplogroup and its SNV frequencies were used. Further, we show that top-level haplogrouping can be achieved by using only 227 specific positions for 99.9% of the tested mitogenomes, potentially making the method available for low-quality samples. The method was tested on two types of datasets: high-quality forensic reference datasets and a diverse collection of scrutinised mitogenomes from GenBank. This dual evaluation demonstrated that the approach is robust across both curated forensic data and broader population-level sequences. This method produced likelihood ratios in the range of 100-100,000, demonstrating its potential to strengthen the statistical evaluation of forensic mtDNA evidence. We have developed an open-source R package `mitofreq` that implements our method, including a Shiny app where custom TLHG frequencies can be supplied.

</details>


<div id='eess.IV'></div>

# eess.IV [[Back]](#toc)

### [5] [Cell Behavior Video Classification Challenge, a benchmark for computer vision methods in time-lapse microscopy](https://arxiv.org/abs/2601.10250)
*Raffaella Fiamma Cabini,Deborah Barkauskas,Guangyu Chen,Zhi-Qi Cheng,David E Cicchetti,Judith Drazba,Rodrigo Fernandez-Gonzalez,Raymond Hawkins,Yujia Hu,Jyoti Kini,Charles LeWarne,Xufeng Lin,Sai Preethi Nakkina,John W Peterson,Koert Schreurs,Ayushi Singh,Kumaran Bala Kandan Viswanathan,Inge MN Wortel,Sanjian Zhang,Rolf Krause,Santiago Fernandez Gonzalez,Diego Ulisse Pizzagalli*

Main category: eess.IV

TL;DR: 该论文组织了细胞行为视频分类挑战赛，评估了35种方法，比较了基于跟踪特征、端到端深度学习以及特征融合三种方法在细胞行为视频分类中的表现。


<details>
  <summary>Details</summary>
Motivation: 显微视频中复杂细胞行为的分类对于理解生物过程动态至关重要，但这是计算机视觉的前沿挑战，需要能够有效建模非刚性边界物体的形状和运动、从整个图像序列提取层次时空特征、并处理视场中多个对象的方法。

Method: 组织细胞行为视频分类挑战赛，评估了35种方法，主要分为三类：1)基于跟踪特征分类；2)端到端深度学习架构直接从整个视频序列学习时空特征；3)融合跟踪特征和图像特征。

Result: 挑战赛结果展示了不同方法在细胞行为视频分类中的表现，为参与者提供了性能比较，并揭示了各种方法的潜力和局限性。

Conclusion: 该研究为促进计算机视觉方法在细胞动力学研究中的发展提供了基础，通过系统比较不同方法，为未来细胞行为视频分析技术的发展指明了方向。

Abstract: The classification of microscopy videos capturing complex cellular behaviors is crucial for understanding and quantifying the dynamics of biological processes over time. However, it remains a frontier in computer vision, requiring approaches that effectively model the shape and motion of objects without rigid boundaries, extract hierarchical spatiotemporal features from entire image sequences rather than static frames, and account for multiple objects within the field of view.
  To this end, we organized the Cell Behavior Video Classification Challenge (CBVCC), benchmarking 35 methods based on three approaches: classification of tracking-derived features, end-to-end deep learning architectures to directly learn spatiotemporal features from the entire video sequence without explicit cell tracking, or ensembling tracking-derived with image-derived features.
  We discuss the results achieved by the participants and compare the potential and limitations of each approach, serving as a basis to foster the development of computer vision methods for studying cellular dynamics.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [6] [Comparative Evaluation of Deep Learning-Based and WHO-Informed Approaches for Sperm Morphology Assessment](https://arxiv.org/abs/2601.10070)
*Mohammad Abbadi*

Main category: cs.LG

TL;DR: 本研究比较了基于图像的深度学习模型HuSHeM与WHO(+SIRI)临床基线方法在精子形态质量评估中的表现，发现深度学习模型在判别性能、校准和临床效用方面均优于传统方法。


<details>
  <summary>Details</summary>
Motivation: 精子形态评估是男性生育力评价的关键但主观的组成部分，受到观察者间变异性和资源限制的影响。需要更客观、可重复的评估方法来提高评估质量。

Method: 开发了基于图像的深度学习模型HuSHeM，在高分辨率精子形态图像上进行训练，并与基于WHO标准并增强系统性炎症反应指数(SIRI)的临床基线方法WHO(+SIRI)进行比较。使用独立临床队列进行评估，通过判别性能、校准分析和临床效用分析来评估模型表现。

Result: HuSHeM模型显示出更高的判别性能（更高的AUC值，置信区间更窄），在类别不平衡情况下表现更好（更高的精确率-召回率面积值），校准分析显示预测概率与观察结果更一致，决策曲线分析表明在临床相关阈值概率下具有更大的净临床效益。

Conclusion: 基于图像的深度学习相比传统的基于规则和炎症增强的标准，可能提供更好的预测可靠性和临床效用。该框架支持精子形态的客观和可重复评估，可作为生育筛查和转诊工作流程中的决策支持工具，但并非旨在取代临床判断或实验室评估。

Abstract: Assessment of sperm morphological quality remains a critical yet subjective component of male fertility evaluation, often limited by inter-observer variability and resource constraints. This study presents a comparative biomedical artificial intelligence framework evaluating an image-based deep learning model (HuSHeM) alongside a clinically grounded baseline derived from World Health Organization criteria augmented with the Systemic Inflammation Response Index (WHO(+SIRI)).
  The HuSHeM model was trained on high-resolution sperm morphology images and evaluated using an independent clinical cohort. Model performance was assessed using discrimination, calibration, and clinical utility analyses. The HuSHeM model demonstrated higher discriminative performance, as reflected by an increased area under the receiver operating characteristic curve with relatively narrow confidence intervals compared to WHO(+SIRI). Precision-recall analysis further indicated improved performance under class imbalance, with higher precision-recall area values across evaluated thresholds. Calibration analysis indicated closer agreement between predicted probabilities and observed outcomes for HuSHeM, while decision curve analysis suggested greater net clinical benefit across clinically relevant threshold probabilities.
  These findings suggest that image-based deep learning may offer improved predictive reliability and clinical utility compared with traditional rule-based and inflammation-augmented criteria. The proposed framework supports objective and reproducible assessment of sperm morphology and may serve as a decision-support tool within fertility screening and referral workflows. The proposed models are intended as decision-support or referral tools and are not designed to replace clinical judgment or laboratory assessment.

</details>
